A groundbreaking Indian study suggests that the tiny organisms residing in our stomachs might hold the key to preserving eyesight. Researchers have discovered that distinct patterns in gut bacteria could assist doctors in identifying diabetic patients who are at risk of developing diabetic retinopathy (DR), a primary cause of vision impairment.
Study Details and Findings
The findings, published in the journal Gut Pathogens, originate from the Diabetic Retinopathy Microbiome Study-India (DRMS-India), conducted in collaboration with Hyderabad's LV Prasad Eye Institute (LVPEI). This nationwide project encompasses 17 centers and over 500 participants, with the initial analysis focusing on 100 individuals: 26 healthy controls, 33 diabetics without eye disease, and 41 patients with diabetic retinopathy.
Stool sample analysis revealed striking differences among the groups. Patients with diabetic retinopathy exhibited a more diverse gut microbiome compared to the other groups. Although common gut bacteria were present across all participants, their proportions varied sharply. Notably, one bacterium, Segatella copri, stood out: it was most abundant in healthy individuals and least abundant in DR patients, hinting at a potential microbial marker for the disease.
Implications for Diabetes Care in India
India bears the world's second-largest diabetes burden, and Hyderabad is often referred to as the country's 'diabetes capital'. With diabetic retinopathy threatening to rob millions of their sight, doctors believe that gut microbiome research could open a new frontier in prevention. The potential is enormous: a simple stool test could one day serve as a non-invasive screening tool. If the same microbial patterns are confirmed in the larger study population, physicians may eventually be able to identify high-risk patients through a routine stool test and initiate treatment before serious vision problems develop.
Dr. Brijesh Takkar, lead author of the study, stated, "We are hoping that the completed study would help improve eye health outcomes for people with diabetes across India. If the results are confirmed in more participants, a simple stool test could help identify diabetic patients who are at risk of developing eye disease, allowing treatment earlier and preventing vision loss."
Dr. Taraprasad Das, one of the authors and vice-chair emeritus at LVPEI, added, "Across diverse geographies and metabolic states, microbial patterns reveal a unique signature of diabetic retinopathy."
Lifestyle, Gut Health, and Disease
The study highlights how lifestyle and gut health may shape disease progression and how the tiniest microbes could help protect vision on a massive scale. As research continues, the hope is that this non-invasive approach will revolutionize the early detection and management of diabetic retinopathy, ultimately reducing the burden of blindness in India and beyond.



